Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A clinical review of delayed-onset side effects from NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) supplementation, including nausea, sleep disruption, methylation burden, and cancer-related signals. Evidence from human trials, FAERS reports, and post-market literature.
Read clinical reviewA clinician-reviewed breakdown of NMN and NR adverse event rates from published human trials, FAERS reports, and post-market literature. Learn which side effects are common, which are rare, and what doses produced them.
Read clinical reviewA clinician-reviewed breakdown of NMN and NR (nicotinamide mononucleotide/riboside) side effects, including rare adverse events, potentially permanent risks, and what current human trial data actually show.
Read clinical reviewA clinical review of rare but serious adverse events linked to NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside), including hepatotoxicity signals, methylation burden, oncology concerns, and what human trial data actually shows.
Read clinical reviewA clinical breakdown of NMN and NR (nicotinamide mononucleotide/riboside) adverse events by severity and patient type, with data from human trials, FAERS reports, and post-market literature.
Read clinical review